TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Inhalation Sciences Sweden AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
17,732
|
11,534
|
9,189 |
| Financial expenses |
1,008
|
97
|
37 |
| Earnings before taxes |
-4,806
|
-11,469
|
-16,197 |
| EBITDA |
-2,674
|
-10,260
|
-15,010 |
| Total assets |
18,405
|
12,283
|
25,465 |
| Current assets |
16,001
|
8,982
|
20,951 |
| Current liabilities |
4,834
|
4,327
|
4,941 |
| Equity capital |
13,123
|
7,144
|
19,190 |
| - share capital |
6,146
|
4,304
|
4,437 |
| Employees (average) |
8
|
9
|
9 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
71.3%
|
58.2%
|
75.4% |
| Turnover per employee |
2,216
|
1,282
|
1,021 |
| Profit as a percentage of turnover |
-27.1%
|
-99.4%
|
-176.3% |
| Return on assets (ROA) |
-20.6%
|
-92.6%
|
-63.5% |
| Current ratio |
331.0%
|
207.6%
|
424.0% |
| Return on equity (ROE) |
-36.6%
|
-160.5%
|
-84.4% |
| Change turnover |
5,379
|
2,622
|
-697 |
| Change turnover % |
44%
|
29%
|
-7% |
| Chg. No. of employees |
-1
|
0
|
1 |
| Chg. No. of employees % |
-11%
|
0%
|
13% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.